Celgene Corporation (CELG) Reports Second Quarter 2013 Operating and Financial Results
7/25/2013 7:56:39 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Celgene Corporation (NASDAQ: CELG) reported net product sales of $1,564 million for the second quarter of 2013, a 17 percent increase from the same period in 2012. Adjusted net income for the second quarter of 2013 increased 20 percent to $653 million compared to $545 million in the second quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.